Latest journal
All journals
October 2021
Welcome to the latest issue of EMJ Cardiology! We are proud to share with you an impressive collection of novel and interesting research, alongside our independent review of the European Society of Cardiology (ESC) Congress 2021, with abstract summaries and late-breaking news from the virtual event.
Figure 1: Vericiguat increases soluble guanylate cyclase activity to improve myocardial and vascular function.
Rea… twitter.com/i/web/status/1…
Posted 03 December
Patients with COVID-19 and cardiovascular disease or hypertension are at greatest risk for severe infection and mor… twitter.com/i/web/status/1…
Posted 02 December
This review explores the evidence that will enable recognition of #cardiac cachexia and improve identification of p… twitter.com/i/web/status/1…
Posted 01 December
Despite the use of guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction… twitter.com/i/web/status/1…
Posted 30 November
Despite the use of guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction… twitter.com/i/web/status/1…
Posted 29 November
